Read this issue’s cover story titled “Specialists navigate changing, challenging landscape of geographic atrophy management.” More knowledge about the diagnosis and manageme ...

Regardless of dosing regimen, patients treated with ranibizumab had a 43% higher incidence of GA, which was a statistically significant increase compared with bevacizumab. The ranibizumab group had ...

Geographic atrophy management could benefit greatly from the combination of novel therapies and AI-driven imaging technology.

CAMBRIDGE, Mass. and SINGAPORE, March 03, 2026 (GLOBE NEWSWIRE) -- Cirrus Therapeutics today announced several business and pipeline updates to support its growth as a leading global ocular immunology ...

—Among patients diagnosed with intermediate-stage age-related macular degeneration, a fair number of eyes in a new analysis showed evidence of geographic atrophy (GA), a leading cause of blindness. It ...

For decades, treatments for macular degeneration have focused on slowing, not restoring vision loss. A new retinal implant is flipping that script, turning patients with geographic atrophy into ...